Extracellular vesicles from women with breast cancer promote an epithelial-mesenchymal transition-like process in mammary epithelial cells MCF10A

Tumor Biology

Volumn 36, Issue 12, 2015, Pages 9649-9659

  Galindo Hernandez, Octavio ^a   Gonzales Vazquez, Cristina ^a   Cortes Reynosa, Pedro ^a   Reyes Uribe, Emmanuel ^a   Chavez Ocaña, Sonia ^b   Reyes Hernandez, Octavio ^b   Sierra Martinez, Mónica ^b   Salazar, Eduardo Perez ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

Breast cancer; EMT; Extracellular vesicles; MCF10A

Indexed keywords

DNA; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NERVE CELL ADHESION MOLECULE; UVOMORULIN; VIMENTIN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST EPITHELIUM CELL; CANCER STAGING; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENZYME RELEASE; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; FEMALE; HUMAN; HUMAN CELL; INTRADUCTAL CARCINOMA; MCF10A CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; BIOSYNTHESIS; BLOOD; BREAST TUMOR; CELL LINE; GENE EXPRESSION REGULATION; MAMMARY GLAND; METABOLISM; PATHOLOGY; PLASMA;

BREAST NEOPLASMS; CELL LINE; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR VESICLES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; NEOPLASM PROTEINS; PLASMA;

EID: 84952876650     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3711-9     Document Type: Article

References (40)

1. Al-Nedawi K, Meehan B, Rak J. Microvesicles: messengers and mediators of tumor progression. Cell Cycle. 2009;8:2014–8.
2. Rak J. Microparticles in cancer. Semin Thromb Hemost. 2010;36:888–906.
3. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–83.
4. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C. Microvesicles. Mediators of extracellular communication during cancer progression. J Cell Sci. 2010;123:1603–11.
5. Ogorevc E, Kralj-Iglic V, Veranic P. The role of extracellular vesicles in phenotypic cancer transformation. Radiol Oncol. 2013;47:197–205.
6. Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biro E, Nieuwland R, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost. 2004;2:1842–51.
7. Thery C, Zitvogel L, Amigorena S. Exosomes. Composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–79.
8. Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J, et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother. 2010;59:841–50.
9. Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: Possible role of a metastasis predictor. Eur J Cancer. 2003;39:184–91.
10. Galindo-Hernandez O, Villegas-Comonfort S, Candanedo F, Gonzalez-Vazquez MC, Chavez-Ocana S, Jimenez-Villanueva X, et al. Elevated concentration of microvesicles isolated from peripheral blood in breast cancer patients. Arch Med Res. 2013;44:208–14.
11. Kong D, Li Y, Wang Z, Sarkar FH. Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins? Cancers (Basel). 2011;3:716–29.
12. Kawamoto T, Ohga N, Akiyama K, Hirata N, Kitahara S, Maishi N, et al. Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis. PLoS One. 2012;7, e34045.
13. Espinosa-Neira R, Mejia-Rangel J, Cortes-Reynosa P, Salazar EP. Linoleic acid induces an EMT-like process in mammary epithelial cells MCF10a. Int J Biochem Cell Biol. 2011;43:1782–91.
14. Hodgson L, Henderson AJ, Dong C. Melanoma cell migration to type IV collagen requires activation of NF-kappaB. Oncogene. 2003;22:98–108.
15. Lopez-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med. 2009;1:303–14.
16. Antonyak MA, Li B, Boroughs LK, Johnson JL, Druso JE, Bryant KL, et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci U S A. 2011;108:4852–7.
17. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006;172:973–81.
18. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–6.
19. Gavert N, Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med. 2008;14:199–209.
20. Hajra KM, Chen DY, Fearon ER. The slug zinc-finger protein represses e-cadherin in breast cancer. Cancer Res. 2002;62:1613–8.
21. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, et al. Deltaef1 is a transcriptional repressor of e-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005;24:2375–85.
22. Dong R, Wang Q, He XL, Chu YK, Lu JG, Ma QJ. Role of nuclear factor kappa b and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of mcf-7 cells. Braz J Med Biol Res. 2007;40:1071–8.
23. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, et al. Nf-kappab is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004;114:569–81.
24. Vader P, Breakefield XO, Wood MJ. Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med. 2014;20:385–93.
25. Rak J. Extracellular vesicles—biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol. 2013;4:21.
26. D'Souza-Schorey C, Clancy JW. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 2012;26:1287–99.
27. Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005;6:622–34.
28. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003;15:740–6.
29. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing e-cadherin expression. Nat Cell Biol. 2000;2:76–83.
30. Baranwal S, Alahari SK. Molecular mechanisms controlling e-cadherin expression in breast cancer. Biochem Biophys Res Commun. 2009;384:6–11.
31. Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation. 2002;106:2442–7.
32. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of n-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000;148:779–90.
33. Bindels S, Mestdagt M, Vandewalle C, Jacobs N, Volders L, Noel A, et al. Regulation of vimentin by sip1 in human epithelial breast tumor cells. Oncogene. 2006;25:4975–85.
34. Min C, Eddy SF, Sherr DH, Sonenshein GE. Nf-kappab and epithelial to mesenchymal transition of cancer. J Cell Biochem. 2008;104:733–44.
35. Radisky ES, Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia. 2010;15:201–12.
36. Radenkovic S, Konjevic G, Jurisic V, Karadzic K, Nikitovic M, Gopcevic K. Values of mmp-2 and mmp-9 in tumor tissue of basal-like breast cancer patients. Cell Biochem Biophys. 2014;68:143–52.
37. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559–64.
38. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.
39. Vella LJ. The emerging role of exosomes in epithelial-mesenchymal-transition in cancer. Front Oncol. 2014;4:361.
40. Turturici G, Tinnirello R, Sconzo G, Geraci F. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol. 2014;306:C621–33.